NCT06812312 (VILRCP) is a NA clinical trial of PCR Trainning in CPR Skills, sponsored by Universitat Jaume I.

Who is sponsoring NCT06812312?

NCT06812312 is sponsored by Universitat Jaume I.

What drugs are being tested in NCT06812312?

Interventions in NCT06812312: PCR Trainning.

What condition does NCT06812312 study?

NCT06812312 studies CPR Skills, CPR Quality Assessment, CPR, Football Players, Coaches.

Is NCT06812312 still recruiting?

NCT06812312 is currently completed. Last updated 27 April 2025.

Last reviewed 2025-04-27 · How we verify

NCT06812312: VILRCP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact of Basic Cardiopulmonary Resuscitation on the Knowledge and Attitude of Professional Football Players and Coaches

Completed NA Last updated 27 April 2025

What this trial tests

NA trial testing PCR Trainning in CPR Skills in 206 participants. Completed in 31 July 2022.

Timeline

15 January 2022

Primary endpoint
30 June 2022

31 July 2022

Quick facts

Lead sponsor	Universitat Jaume I
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	206
Start date	15 January 2022
Primary completion	30 June 2022
Estimated completion	31 July 2022
Sites	1 location across Spain

Drugs / interventions tested

PCR Trainning

Conditions studied

CPR Skills — all drugs for CPR Skills →
CPR Quality Assessment — all drugs for CPR Quality Assessment →
CPR — all drugs for CPR →
Football Players — all drugs for Football Players →

Sponsor

Universitat Jaume I — full company profile →

Who can join

Adults 18 to 65, any sex, with CPR Skills or CPR Quality Assessment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the change in attitudes and knowledge about basic cardiopulmonary resuscitation (CPR-B) in football professionals following a training intervention and to examine its correlation with sociodemographic variables. The study consists of two phases. The first phase involves an observational cross-sectional study to assess the level of attitude and knowledge in cardiopulmonary resuscitation. The second phase includes an educational intervention consisting of a training and practical session on CPR-B, with a pre-post intra-subject control. The questionnaire was completed by football professionals from the Spanish first division and their coaches, with N=206 in the first phase and N=70 30 days after the training intervention in the second phase.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of basic cardiopulmonary resuscitation training on the knowledge and attitudes of professional football players and coaches.
González-Moret R, Almodóvar-Fernández I, Simón-Montolio S, Usó-Vicent H, et al · · 2025 · PMID 40486536 · DOI 10.1177/20503121251341107

Verify or expand the search:

Other Universitat Jaume I trials

Trials by the same sponsor.

NCT07202975 — RE-SCALE: Rehabilitation Engagement and Scaled Access With eXtended Reality and Artificial Intelligence · NA · not yet recruiting
NCT07345117 — Cost-effectiveness and Implementation of a Transdiagnostic Internet-based Intervention for Emotional Disorders in Commun · NA · not yet recruiting
NCT06932120 — Technology-supported Interventions for Prolonged Grief Disorder (PGD) · NA · recruiting
NCT06788119 — Analyzing the Benefits of Using SYMPTOMS-JIT for in Vivo Exposure in Anxiety Disorders · NA · recruiting
NCT06839573 — Effectiveness of Immersive Virtual Reality in Nursing Students' Learning · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06812312 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitat Jaume I
Last refreshed: 27 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06812312.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing